SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions ...
Clinical teams face continual challenges when treating pediatric acquired and congenital heart disease. In severe cases, pediatric heart disease can progress to premature heart failure (HF), posing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results